News Sentiment

4594 sentiment intelligence

BrightPath Biotherapeutics Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 50 Balanced news tone 4 relevant articles
Exchange JPX Japan
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 50.00 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

71/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+8.7% over one week, +13.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Enterprise value to revenue forward of BrightPath Biotherapeutics Co.Ltd. – TSE:4594

Market Reaction

Price moving ahead of tone

55/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 71/100 classification
One-week reaction 8.7% Price confirming higher
Trend fit Trend inactive 13.6% over four weeks
Fair value -24.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 2
TipRanks 1
CRISPR Medicine News 1

Event Lens

What the news is about

Classified themes
Market update 3
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4